Sep 08,2022

United States Healthcare Virtual Visits Market Report 2022: Vendors Focus on Inorganic Growth through M&A

Virtual visits are useful tools for continuous monitoring of chronic conditions and treatment. Virtual visit services and technologies can help address current health issues in the US and, in turn, help deliver quality and convenient patient care. The key players in the virtual visit market are AMD Global Telemedicine, American Well, and Teladoc Health.

View Analyst & Ambassador Comments
Go to original news
Sep 08,2022

BD Appoints Two Business Unit Presidents

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced Puneet Sarin has been named president of BD Medication Management Solutions, and Steve Conly has been named president of BD Biosciences, both effective Oct. 3.

View Analyst & Ambassador Comments
Go to original news
Jan 12,2022

Roche Launches the cobas® pulse System

Roche today announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performance blood glucose meter with simple usability and expanded digital capabilities similar to that of a smartphone. At the time of launch, Roche has already secured partnerships with several innovative companies and start-ups in the field (e.g. S4DX, imito, decide (GlucoTab), Glytec, CardioSignal, and SteadySense (SteadyTemp)).

PRODUCT

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 13,2021

Rimidi Grows Client Base 600% in 2020 as Providers Seek to Streamline Workflows and Implement Remote Patient Monitoring Technology as a Result of COVID-19

To further meet new patient and provider demands, company also expands its solution set and enhances platform capabilities

View Analyst & Ambassador Comments
Go to original news
Jan 01,2021

Time in range–A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study

The availability of easily accessible continuous glucose monitoring (CGM) metrics can improve glycemic control in diabetes, and they may even become a viable alternative to hemoglobin A1c (HbA1c) laboratory tests in the next years. The REALISM-T1D study (REAl-Life glucoSe Monitoring in Type 1 Diabetes) was aimed at contributing, with real-world data, to a deeper understanding of these metrics, including the time in range (TIR)–HbA1c relationship, to facilitate their adoption by diabetologists in everyday practice.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 01,2021

Service user and community clinician design of a partially virtual diabetic service improves access to care and education and reduces amputation incidence

From 2017 virtual practice multidisciplinary patient reviews, virtual referral of foot cases and non-face-to-face helplines were developed. A National Health Service (NHS) approved ‘App’ and web-based personalized education support for those recently diagnosed with diabetes was introduced.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 01,2021

Feasibility study of real-time online text-based CBT to support self-management for people with type 1 diabetes: the Diabetes On-line Therapy (DOT) Study

This study examines the feasibility of conducting diabetes-focused cognitive–behavioral therapy (CBT) via a secure online real-time instant messaging system intervention to support self-management and improve glycemic control in people with type 1 diabetes.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 05,2021

Brighter announced two distribution agreements regarding Nigeria and Ghana

Brighter signs 5-year agreement and receives initial order from Actiste® worth EUR 2.3 million in Nigeria" and "Brighter signs 5-year agreement and receives initial order from Actiste ® worth EUR 1.2 million in Ghana

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jan 06,2021

Liva Healthcare secures access to €24.5m funding – led by Verlinvest and supported by the existing investors

Liva Healthcare (“Liva”), a European market leader in scalable digital health coaching, has secured a new funding round with access to EUR 24.5 million, led by Verlinvest, the go-to investor for mission-driven entrepreneurs and category-defining global consumer brands. 

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 07,2021

Diabeloop SA. and SFC Fluidics Inc. announce development agreement for the United States

SFC Fluidics Inc., developer of an Alternate Controller Enabled (ACE) insulin delivery pod and Diabeloop, pioneer in therapeutic artificial intelligence, are partnering to integrate the SFC ACE insulin pod into Diabeloop’s Automated Insulin Delivery (AID) solution. The agreement includes a full US-adaptation of the system.

COLLABORATION PARTNERSHIP

#connected device

#closed loop

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES